239 related articles for article (PubMed ID: 36440963)
1. PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis.
van de Beek I; Glykofridis IE; Oosterwijk JC; van den Akker PC; Diercks GFH; Bolling MC; Waisfisz Q; Mensenkamp AR; Balk JA; Zwart R; Postma AV; Meijers-Heijboer HEJ; van Moorselaar RJA; Wolthuis RMF; Houweling AC
Hum Mol Genet; 2023 Mar; 32(7):1223-1235. PubMed ID: 36440963
[TBL] [Abstract][Full Text] [Related]
2. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
[TBL] [Abstract][Full Text] [Related]
3. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
4. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
5. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
[TBL] [Abstract][Full Text] [Related]
7. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
Furuya M; Nakatani Y
Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
[TBL] [Abstract][Full Text] [Related]
8. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
9. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
10. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
12. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
[TBL] [Abstract][Full Text] [Related]
13. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
Li T; Ning X; He Q; Gong K
Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
[TBL] [Abstract][Full Text] [Related]
14. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
[TBL] [Abstract][Full Text] [Related]
15. A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.
Bandini E; Zampiga V; Cangini I; Ravegnani M; Arcangeli V; Rossi T; Mammi I; Schiavi F; Zovato S; Falcini F; Calistri D; Danesi R
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569793
[TBL] [Abstract][Full Text] [Related]
16. FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome.
Hofstedter R; Sanabria-Salas MC; Di Jiang M; Ezzat S; Mete O; Kim RH
Endocr Pathol; 2023 Jun; 34(2):257-264. PubMed ID: 36701047
[TBL] [Abstract][Full Text] [Related]
17. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
19. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
[TBL] [Abstract][Full Text] [Related]
20. [Birt-Hogg-Dubé syndrome: an update].
López V; Jordá E; Monteagudo C
Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
